Smart Selecta® Duet™ represents Lumenis’ most advanced anterior segment laser platform, combining the advantages of YAG photodisruption capabilities along with the innovative Selective Laser Trabeculoplasty (SLT) technology, both developed and brought to market by Lumenis. Now, it’s also available with SmartV, allowing on-axis and off-axis illumination of vitreous opacities. The system’s fully integrated design, enhanced optics and advanced laser cavity make the Duet one of the best performing laser products in its segment. The Duet is also upgradeable – allowing further extension of the system’s capabilities by adding photocoagulation technology at any point in time.

Advanced SLT & YAG laser system for glaucoma treatment and posterior capsulotomy, featuring digital workflow integration and automated clinical reporting for optimized efficiency.

Steven Dell, MD and Derek Cunningham, OD get a hands-on look at the improved digital capabilities of the newly released Digital Duet/Trio. 

In Africa, glaucoma presents a uniquely difficult problem, as its high prevalence is compounded by economic barriers to essential medical care. Selective laser trabeculoplasty (SLT) is a potentially transformative modality in this setting, presenting an opportunity for quick, safe, and effective long-term treatment. During a trip to Togo, West Africa, Dr.Shlomo Melamed, MD and his colleagues taught local ophthalmologists to perform SLT using Digital Duet.

Hear Jaime Chung and James Deom, OD, discussing the unique benefits of OptiLIGHT. Designed to target the root cause of dry eyes, OptiLIGHT by Lumenis stops the dry eye vicious cycle of inflammation.

Videos below: LightSheer DUET – Comparison on a man’s back LightSheer DUET – Comparison on a woman’s legs Duet comparison woman’s lower legs, axilla

Treat More | Attract More | Convert More | Make More High Speed LightSheer Duet will also change your staff’s perception of laser hair removal and significantly improve patient flow.

Incorporating OptiLIGHT into my practice has made a real difference in patients with meibomian gland dysfunction (MGD) and evaporative dry eye. Lumenis light therapy is the first and only that is FDA-approved for DED, and that is a strong affirmation of safety and efficacy for doctors who are considering implementing OptiLIGHT in their practice as well.

Laser hair removal targets the entire hair structure, from the hair shaft, down to the follicle, meeting the principle of selective photothermolysis. Light energy with a specific wavelength is primarily absorbed by the endogenous chromophore melanin resulting in rapid heating which is required for local thermal necrosis of the follicles’ regenerative structures. To achieve permanent hair removal, the laser system must be able to effectively treat the different hair types and colors as well as the various skin types while providing maximum skin protection. The laser’s wavelength, pulse duration and spot size determine the effectiveness of the treatment (on all skin types) and also influence the depth of penetration and treatment speed.

Introducing OptiLIGHT – a bright solution for dry eyes. OptiLIGHT elevates dry eye management with Lumenis’ patented Optimal Pulse Technology (OPT™) and user-centered design. Get the safe, precise, elegant procedure you want and the comfortable, effective therapy your patients need to manage dry eye disease with OptiLIGHT.